Paula G. Miller

Paula G. Miller

Auto-generated profile, based on publicly available information

Paula G. Miller

Department of Biomedical Engineering Cornell University Ithaca New York USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2016 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
PMPaula G. Miller
Paula G. Miller
MSMichael L. Shuler
Michael L. Shuler

4 June 2018 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
HCHuanhuan Joyce Chen
Huanhuan Joyce Chen
PMPaula Miller
Paula Miller
MSMichael L. Shuler
Michael L. Shuler
We describe an expanded modular gastrointestinal (GI) tract–liver system by co-culture of primary human intestinal epithelial cells (hIECs) and 3D liver mimic. The two organ body-on-chip design consisted of GI and liver tissue compartments that were connected by fluidic medium flow driven via gravity. The hIECs and HepG2 C3A liver cells in the co-culture system maintained high viability for at least 14 days in which hIECs differentiated into major cell types found in native human intestinal epithelium and the HepG2 C3A cells cultured on 3D polymer scaffold formed a liver micro-lobe like structure. Moreover, the hIECs formed a monolayer on polycarbonate membranes with a tight junction and authentic TEER values of approximately 250 Ω cm2 for the native gut. The hIEC permeability was compared to a conventional permeability model using Caco-2 cell response for drug absorption by measuring the uptake of propranolol, mannitol and caffeine. Metabolic rates (urea or albumin production) of the cells in the co-culture GI–liver system were comparable to those of HepG2 C3A cells in a single-organ fluidic culture system, while induced CYP activities were significantly increased in the co-culture GI tract–liver system compared to the single-organ fluidic culture system. These results demonstrated potential of the low-cost microphysiological GI–liver model for preclinical studies to predict human response.

14 October 2019 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
PMPaula G. Miller
Paula G. Miller
CCChen‐Yu Chen
Chen‐Yu Chen
YWYing I. Wang
Ying I. Wang
EGEmily Gao
Emily Gao
MSMichael L. Shuler
Michael L. Shuler

4 December 2020 in Biotechnology Progress
Verified
Journal Article
Closed access
PDF file
DLDanielle J. LaValley
Danielle J. LaValley
PMPaula G. Miller
Paula G. Miller
MSMichael L. Shuler
Michael L. Shuler

9 June 2017 in Biotechnology Progress
Verified
Journal Article
Closed access
PDF file
PMPaula G. Miller
Paula G. Miller
YWYing I. Wang
Ying I. Wang
GSGlen Swan
Glen Swan
MSMichael L. Shuler
Michael L. Shuler

22 March 2017 in World Journal for Pediatric and Congenital Heart Surgery
Verified
Journal Article
Closed access
BKBrian E. Kogon
Brian E. Kogon
KMKati Miller
Kati Miller
PMPaula Miller
Paula Miller
BABahaaldin Alsoufi
Bahaaldin Alsoufi
JRJoshua M. Rosenblum
Joshua M. Rosenblum
Background: The Adult Congenital Heart Association (ACHA) is dedicated to supporting patients with congenital heart disease. To guide patients to qualified providers and programs, it maintains a publicly accessible directory of dedicated adult congenital cardiac programs. We analyzed the directory in 2006 and 2015, aiming to evaluate the growth of the directory as a whole and to evaluate the growth of individual programs within the directory. We also hope this raises awareness of the growing opportunities that exist in adult congenital cardiology and cardiac surgery. Methods: Data in the directory are self-reported. Only data from US programs were collected and analyzed. Results: By the end of 2015, compared to 2006, there were more programs reporting to the directory in more states (107 programs across 42 states vs 57 programs across 33 states), with higher overall clinical volume (591 vs 164 half-day clinics per week, 96,611 vs 34,446 patient visits). On average, each program was busier (5 vs 2 half-day clinics per week per program). Over the time period, the number of reported annual operations performed nearly doubled (4,346 operations by 210 surgeons vs 2,461 operations by 125 surgeons). Access to ancillary services including specific clinical diagnostic and therapeutic services also expanded. Conclusion: Between 2006 and 2015, the clinical directory and the individual programs have grown. Current directory data may provide benchmarks for staffing and services for newly emerging and existing programs. Verifying the accuracy of the information and inclusion of all programs will be important in the future.